Bloomberg News

Novacap Buys Salicylic and Paracetamol Activities From Rhodia

By Francois de Beaupuy
November 02, 2011

Nov. 2 (Bloomberg) -- Novacap, a French chemicals maker partly owned by Axa Private Equity, said it bought the salicylic and paracetamol activities of Solvay SA’s Rhodia for an undisclosed sum.

To contact the editor responsible for this story: Francois de Beaupuy at fdebeaupuy@bloomberg.net

Business Exchange: What your peers are reading.

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus